Table 1.

Recommended dosage and schedule of eculizumab for patients with atypical hemolytic uremic syndrome

Body weight, kg	≥40	30 to <40	20 to <30	10 to <20	5 to <10
Induction period, mg/wk	900 for wk 1, 2, 3, 4	600 for wk 1, 2	600 for wk 1, 2	600 for wk 1	300 for wk 1
Maintenance period, mg	1,200 during wk 5, then 1,200 every 2 wk	900 during wk 3, then 900 every 2 wk	600 during wk 3, then 600 every 2 wk	300 during wk 2, then 300 every 2 wk	300 during wk 2, then 300 every 3 wk